Vicarious Surgical (NYSE:RBOT) Stock Price Down 3.3% – Here’s Why

Vicarious Surgical Inc. (NYSE:RBOT) traded down 3.3% during trading on Tuesday . The company traded as low as $0.9356 and last traded at $0.96. 31,762 shares were traded during mid-day trading, a decline of 59% from the average session volume of 78,202 shares. The stock had previously closed at $0.9929.

Analysts Set New Price Targets

Separately, Wall Street Zen downgraded shares of Vicarious Surgical from a “hold” rating to a “sell” rating in a report on Saturday, March 7th. Two research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and an average price target of $7.00.

Vicarious Surgical Stock Down 3.3%

The firm’s 50-day moving average price is $0.75 and its two-hundred day moving average price is $1.79. The firm has a market capitalization of $6.84 million, a PE ratio of -0.11 and a beta of 1.49.

Vicarious Surgical (NYSE:RBOT) last released its earnings results on Monday, March 9th. The company reported ($1.65) earnings per share for the quarter, missing the consensus estimate of ($1.37) by ($0.28). Equities research analysts forecast that Vicarious Surgical Inc. will post -10.89 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Armistice Capital LLC purchased a new position in shares of Vicarious Surgical in the fourth quarter worth approximately $1,314,000. Connective Capital Management LLC purchased a new position in shares of Vicarious Surgical in the third quarter worth approximately $169,000. Dimensional Fund Advisors LP increased its position in shares of Vicarious Surgical by 22.1% in the third quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock worth $110,000 after acquiring an additional 3,615 shares in the last quarter. Jane Street Group LLC purchased a new position in Vicarious Surgical during the fourth quarter valued at approximately $98,000. Finally, Geode Capital Management LLC grew its position in Vicarious Surgical by 26.0% during the fourth quarter. Geode Capital Management LLC now owns 40,494 shares of the company’s stock valued at $88,000 after purchasing an additional 8,344 shares in the last quarter. 47.27% of the stock is owned by hedge funds and other institutional investors.

Vicarious Surgical Company Profile

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.